So then why doesnt another big pharmaceutical company swoop in, buy the patent, and use their exhaustive funds to get BPC FDA approved, then make billions of dollars selling the drug to an already interested market
Synergistic Integration Together, these three peptides address the complete regeneration cascade: initial response and inflammation control (BPC-157), cellular migration and reorganization (TB-500), and extracellular matrix synthesis and maturation (GHK-Cu)
Over time, telomeres shorten
Tendon tissue is normally hypovascular, so this is significant
Acta Med
Reported concerns include local injection reactions, potential immunogenicity from copper exposure with chronic use, and theoretical risks if peptides activate unintended growth pathways